abstract |
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of making and using compounds of formula (I) and pharmaceutical compositions comprising such compounds. The compounds of formula (I) are LMP7 inhibitors and may be useful in treating related inflammatory diseases and disorders such as rheumatoid arthritis, lupus, and irritable bowel disease. |